Synthetic SIGLEC9-based chimeric switch receptor augments the efficacy of CAR macrophages against glioblastoma

已完结 20 由 sailor 发布于 2026/4/13 16:12:48

DOI:10.1073/pnas.2519819123
作者：Zhipeng Fu, Xiaotian Zhao, Qikang Zhang, Maosen Han, Jing Zhang, Zhenmei Yang, Yan Wang, Zichao Yao, Ying Liu, Chunwei Tang, Kaiyan Xi, Zhanyan Liu, Yi Zhang, Kun Zhao, Na Li, Yulin Zhang, Yudong Song
文献类型：期刊论文
补充材料：只需要正文
文献链接：https://doi.org/10.1073/pnas.2519819123

Proceedings of the National Academy of Sciences of the United States of America (PNAS)

Abstract：Chimeric antigen receptor macrophage (CAR-M) therapy represents a promising therapeutic approach for treating glioblastoma multiforme (GBM). However, durable antitumorigenic macrophage pheno

应助信息

16小时前

rshen

ff681317371211f1ba6d34735aa3bc31.pdf 已采纳

17小时前

Book学术机器人

2026/4/13 16:12:48 未找到该文献，机器人已退出，请等待人工下载

2026/4/13 16:12:48 Book学术AI机器人收到请求，开始寻找文献

2026/4/13 16:12:48 已向机器人发送请求

17小时前

sailor 发布求助

上一个求助:其它数据库Naturally Fractured Carbonate Reservoir Characterization: A Case Study of a Mature High-Pour Point Oil Field in Hungary 下一个求助:其它数据库Evaluating the Income Tax Redistributive Impact: A More Comprehensive Approach